Results 71 to 80 of about 3,500 (175)

Multimodal therapy and precision-imaging extends the limits of treatment for a patient with initially unresectable synchronous colorectal liver metastases. [PDF]

Ann R Coll Surg Engl
Sidhom M, Morrison-Jones V, Harinarayanan S, Nolan L, Welsh F.   +4 more
europepmc   +1 more source

Colorectal Cancer with Ovarian Metastasis After Panitumumab and FOLFOX4: A Case Report. [PDF]

Am J Case Rep
Koper A, Wileński S, Koper K.
europepmc   +1 more source

Maintaining oxaliplatin therapy after hypersensitivity reactions: real-world experience with a desensitisation protocol. [PDF]

Clin Exp Med
Christodoulis E, Vlachostergios PJ, Connell J, Williams J, Hasan J, Mansoor W, Mullamitha S, Hubner RA, Braun M, Saunders MP, Marti Marti F, Angelakas A, Waddell T, Alam N, Kamposioras K.   +14 more
europepmc   +1 more source

Molecular Dynamics Simulation of Passive Diffusion across a Human Breast Cancer Cell Membrane Model. Comparison between Cisplatin and Its Pt(IV) Derivatives. [PDF]

J Chem Inf Model
Belletto D, Scoditti S, Borocci S, Sanna N, Zazza C, Sicilia E.   +5 more
europepmc   +1 more source

5-Fluorouracil-Related Lactic Acidosis in a Patient with Colon Cancer. [PDF]

Intern Med
Osawa Y, Kazaoka M, Akita T, Nemoto D, Ohtake T.   +4 more
europepmc   +1 more source

Platinum-Based Cytostatics Used in Oncology with Respect to Environmental Fate and Innovative Removal Strategies of Their Metabolites. [PDF]

Molecules
Olchowski R, Morlo K, Dobrowolski R.
europepmc   +1 more source

Recurrent Cytokine Release Syndrome in Metastatic Gastric Cancer on Nivolumab-FOLFOX: A Case Report and Mechanistic Review. [PDF]

J Gastrointest Cancer
Islam J, Rashid Z, Munster AB, Hughes P, Badzek S, Huda I.   +5 more
europepmc   +1 more source

Atezolizumab plus FOLFOX for Stage III Mismatch Repair-Deficient Colon Cancer. [PDF]

N Engl J Med
Sinicrope FA, Ou FS, Arnold D, Peters WR, Behrens RJ, Lieu CH, Matin K, Cohen DJ, Potter SL, Nixon AB, Kottschade LA, Kathol E, Frankel WL, Shergill A, Hsu D, Reinacher-Schick A, Mehan P, Gold PJ, Khalil MF, Zemla T, Gatten C, O'Reilly EM, Meyerhardt JA.   +22 more
europepmc   +1 more source

Crizotinib- or Ceritinib-Conjugated Platinum(IV) Prodrugs As Potent Multiaction Agents Inducing Antiproliferative Effects in 2D and 3D Cancer Cell Models. [PDF]

J Med Chem
Sharkawy S, Acharya S, Kostrhunová H, Maji M, Marková L, Novohradský V, Gibson D, Brabec V.   +7 more
europepmc   +1 more source

A randomized, double-blind, placebo-controlled trial of olanzapine versus placebo plus ondansetron and dexamethasone for antiemetic prophylaxis in patients receiving oxaliplatin-, irinotecan-, or carboplatin-based chemotherapy. [PDF]

Support Care Cancer
Harikul W, Nimmannit A, Laocharoenkeat A, Phisalprapa P, Kositamongkol C, Thongkijpreecha P, Ithimakin S.   +6 more
europepmc   +1 more source